- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 409.05M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 405.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 360.51M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.78M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.14M |
| Capex | Q1 2026 · Mar 31, 2026 | $553.99M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $99.68M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $91.53M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$47.24M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $4.38B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.71B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $355.35M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $37.79M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $715.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $628.26M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $23.17M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $714.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $805.54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $734.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $681.95M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.25B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $699.07M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.65B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.46B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.89B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.65B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.29B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $11.74M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $8.95M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$114.32M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$38.98M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$114.57M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$38.09M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $17.71M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $14.89M |
| Revenue | Q1 2026 · Mar 31, 2026 | $34.84M |
| Revenue | Q1 2026 · Mar 31, 2025 | $48.96M |